Mycophenolate

Intervention

1 paper studies it14 more mention it2 findings

PubChemChEBI

  • 1 lab in 1 country
  • 1 finding against
  • 2 trials, none about aging
  • Funders: American Thoracic Society and others
  • Humans1

Outcomes

1

Mortality

no changein humans1

1 study
  1. Mycophenolate has no effect on mortality in humans.

    “Immunosuppressant exposure was not associated with differential survival in patients with LTL ≥10th percentile.”

    Humansin patients with LTL >=10th percentile2-year

    Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease

    The European respiratory journal

Associations

1

Mortality

upin humans1HR 4.97

1 study
  1. Mycophenolate raises the risk of mortality in humans (HR 4.97, 95% CI 2.26-10.92, p<0.001).

    “fHP and uILD patients with LTL <10th percentile experienced reduced survival when exposed to either mycophenolate or azathioprine in the discovery cohort (mortality hazard ratio (HR) 4.97, 95% CI 2.26-10.92; p<0.001)”

    Humansin fHP and uILD patients with LTL <10th percentile (discovery cohort)2-yearn = 613

    Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease

    The European respiratory journal

Trial sponsors

Latest

Nov 2025: 1Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 2Aug 2026: 0Sep 2026: 0Oct 2026: 03 papers in 12 months